Dr. Howard M. Gross
Claim this profileKettering Medical Center
About Howard M. Gross
Education:
- Obtained MD (Doctor of Medicine) from the University of Cincinnati College of Medicine in 1986.
Experience:
- Board Certified in Internal Medicine by the American Board of Internal Medicine.
- Has been practicing medicine since 1986, specializing in internal medicine.
- Affiliated with Miami Valley Hospital North and other Dayton area medical facilities.
Area of expertise
Breast Cancer
Howard M. Gross has run 23 trials for Breast Cancer. Some of their research focus areas include:
Cancer
Howard M. Gross has run 21 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
Kettering Medical Center
Dayton Physician LLC-Miami Valley Hospital North
Clinical Trials Howard M. Gross is currently running
Chemotherapy + Immunotherapy
for Esophageal and Gastric Cancer
This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil, leucovorin calcium, and oxaliplatin (mFOLFOX) for the treatment of advanced, unresectable, or metastatic HER2 negative esophageal, gastroesophageal junction, and gastric adenocarcinoma. The usual approach for patients is treatment with FOLFOX chemotherapy. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Fluorouracil stops cells from making DNA and it may kill tumor cells. Leucovorin is used with fluorouracil to enhance the effects of the drug. Oxaliplatin works by killing, stopping, or slowing the growth of tumor cells. Some patients also receive an immunotherapy drug, nivolumab, in addition to FOLFOX chemotherapy. Immunotherapy may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Irinotecan blocks certain enzymes needed for cell division and DNA repair, and it may kill tumor cells. Adding irinotecan to the FOLFOX regimen could shrink the cancer and extend the life of patients with advanced gastroesophageal cancers.
Recruiting
2 awards
Phase 3
2 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting
2 awards
Phase 3
19 criteria
More about Howard M. Gross
Clinical Trial Related
7 years of experience running clinical trials · Led 134 trials as a Principal Investigator · 56 Active Clinical Trials
Treatments Howard M. Gross has experience with
- Nivolumab
- Pembrolizumab
- Carboplatin
- Paclitaxel
- Cisplatin
- Atezolizumab
Breakdown of trials Howard M. Gross has run
Breast Cancer
Cancer
Breast cancer
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Howard M. Gross specialize in?
Howard M. Gross focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are Stage IV.
Is Howard M. Gross currently recruiting for clinical trials?
Yes, Howard M. Gross is currently recruiting for 56 clinical trials in Kettering Ohio. If you're interested in participating, you should apply.
Are there any treatments that Howard M. Gross has studied deeply?
Yes, Howard M. Gross has studied treatments such as Nivolumab, Pembrolizumab, Carboplatin.
What is the best way to schedule an appointment with Howard M. Gross?
Apply for one of the trials that Howard M. Gross is conducting.
What is the office address of Howard M. Gross?
The office of Howard M. Gross is located at: Kettering Medical Center, Kettering, Ohio 45429 United States. This is the address for their practice at the Kettering Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.